Gennaro D'Amico

Summary

Country: Italy

Publications

  1. ncbi Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
    Guadalupe Garcia-Tsao
    Gastroenterology Unit, Ospedale Cervello and University of Palermo, Italy
    J Hepatol 44:217-31. 2006
  2. ncbi Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis
    Gennaro D'Amico
    Department of Medicine, Ospedale V Cervello, Palermo, Italy
    Gastroenterology 124:1277-91. 2003
  3. ncbi Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators
    Gennaro D'Amico
    Department of Medicine, Ospedale V Cervello, Palermo, Italy
    Hepatology 38:599-612. 2003
  4. ncbi The role of vasoactive drugs in the treatment of oesophageal varices
    Gennaro D'Amico
    Divisione di Medicina Generale, Ospedale V Cervello, Palermo, Italy
    Expert Opin Pharmacother 5:349-60. 2004
  5. ncbi Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis
    Gennaro D'Amico
    Unit of Gastroenterology, Ospedale V Cervello, Palermo, Italy
    Gastroenterology 129:1282-93. 2005
  6. ncbi Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial
    Aurelio Maggio
    U O C Ematologia II con Talassemia, A O V Cervello, Palermo, Italy
    Br J Haematol 145:245-54. 2009
  7. ncbi Impact of gluten withdrawal on health-related quality of life in celiac subjects: an observational case-control study
    Gian Eugenio Tontini
    University of Milan, Milan, Italy
    Digestion 82:221-8. 2010
  8. ncbi Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures
    Daniela Scimeca
    Department of Medicine, Pneumology and Nutrition Clinic, V Cervello Hospital, Palermo University, Palermo, Italy
    Dig Liver Dis 43:121-5. 2011
  9. ncbi Delayed-onset superior mesenteric artery syndrome presenting as oesophageal peptic stricture
    Emanuele Sinagra
    Operative Unit of Gastroenterology, Palermo University, Palermo, Italy
    Case Rep Gastroenterol 6:94-102. 2012
  10. ncbi Familial clustering of (mostly) HCV-related cirrhosis. A case-control study
    Luigi Pagliaro
    Clinica Medica R, Universita degli Studi, Palermo, Italy
    J Hepatol 37:762-6. 2002

Collaborators

Detail Information

Publications12

  1. ncbi Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
    Guadalupe Garcia-Tsao
    Gastroenterology Unit, Ospedale Cervello and University of Palermo, Italy
    J Hepatol 44:217-31. 2006
  2. ncbi Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis
    Gennaro D'Amico
    Department of Medicine, Ospedale V Cervello, Palermo, Italy
    Gastroenterology 124:1277-91. 2003
    ..We performed a meta-analysis comparing emergency sclerotherapy with pharmacologic treatment...
  3. ncbi Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators
    Gennaro D'Amico
    Department of Medicine, Ospedale V Cervello, Palermo, Italy
    Hepatology 38:599-612. 2003
    ..Initial treatment stops bleeding in 90% of patients. Accurate predictive rules are provided for early recognition of high-risk patients...
  4. ncbi The role of vasoactive drugs in the treatment of oesophageal varices
    Gennaro D'Amico
    Divisione di Medicina Generale, Ospedale V Cervello, Palermo, Italy
    Expert Opin Pharmacother 5:349-60. 2004
    ..Because of their high clinical efficacy, safety, ease of use and low cost, vasoactive drugs should be considered the first choice treatment for oesophageal varices...
  5. ncbi Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis
    Gennaro D'Amico
    Unit of Gastroenterology, Ospedale V Cervello, Palermo, Italy
    Gastroenterology 129:1282-93. 2005
    ..We performed a systematic review of randomized controlled trials of TIPS for refractory ascites to assess the overall treatment effects and to explore potential reasons of heterogeneity...
  6. ncbi Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial
    Aurelio Maggio
    U O C Ematologia II con Talassemia, A O V Cervello, Palermo, Italy
    Br J Haematol 145:245-54. 2009
    ....
  7. ncbi Impact of gluten withdrawal on health-related quality of life in celiac subjects: an observational case-control study
    Gian Eugenio Tontini
    University of Milan, Milan, Italy
    Digestion 82:221-8. 2010
    ..To evaluate health-related quality of life (HRQoL) in celiac disease (CD) patients at the time of diagnosis and during a gluten-free diet (GFD)...
  8. ncbi Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures
    Daniela Scimeca
    Department of Medicine, Pneumology and Nutrition Clinic, V Cervello Hospital, Palermo University, Palermo, Italy
    Dig Liver Dis 43:121-5. 2011
    ..To evaluate prospectively the clinical efficacy and safety of endoscopic hydrostatic balloon dilation in a consecutive cohort of symptomatic intestinal Crohn's disease strictures...
  9. ncbi Delayed-onset superior mesenteric artery syndrome presenting as oesophageal peptic stricture
    Emanuele Sinagra
    Operative Unit of Gastroenterology, Palermo University, Palermo, Italy
    Case Rep Gastroenterol 6:94-102. 2012
    ..Symptoms improved after (par)enteral nutrition and repeated oesophageal dilatation, thus supporting the role of intensive medical and endoscopic intervention as an alternative to surgery, at least in some cases...
  10. ncbi Familial clustering of (mostly) HCV-related cirrhosis. A case-control study
    Luigi Pagliaro
    Clinica Medica R, Universita degli Studi, Palermo, Italy
    J Hepatol 37:762-6. 2002
    ..Increased prevalence of cirrhosis in cirrhotics' families in previous studies...
  11. ncbi An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C
    Fabio Tinè
    Unità operativa di Gastroenterologia e Medicina, Ospedali Riuniti Villa Sofia e Cervello, Palermo, Italy
    Pharmacoepidemiol Drug Saf 19:1113-23. 2010
    ..Treatment of patients with chronic hepatitis C with alpha-interferon and ribavirin usually produces adverse events within the first 3 months. We aimed to assess safety and predictors of discontinuation or dose modification of these drugs...
  12. ncbi Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial
    Aurelio Maggio
    Divisione di Ematologia II e Unità di Ricerca Piera Cutino, Azienda Ospedaliera V Cervello, Palermo, Italy
    Blood Cells Mol Dis 28:196-208. 2002
    ..These findings suggest that deferiprone may be as effective as deferoxamine in the treatment of thalassemia major with few mild and reversible side effects...